- Home
- GERN vs ERO Comparison
GERN vs ERO Comparison
Compare GERN & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- ERO
- Stock Information
- Founded
- GERN 1990
- ERO 2016
- Country
- GERN United States
- ERO Canada
- Employees
- GERN N/A
- ERO N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- ERO
- Sector
- GERN Health Care
- ERO
- Exchange
- GERN Nasdaq
- ERO Nasdaq
- Market Cap
- GERN 1.5B
- ERO 1.5B
- IPO Year
- GERN 1996
- ERO N/A
- Fundamental
- Price
- GERN $2.57
- ERO $12.80
- Analyst Decision
- GERN Strong Buy
- ERO Strong Buy
- Analyst Count
- GERN 11
- ERO 1
- Target Price
- GERN $6.82
- ERO $19.00
- AVG Volume (30 Days)
- GERN 12.4M
- ERO 531.6K
- Earning Date
- GERN 02-26-2025
- ERO 03-06-2025
- Dividend Yield
- GERN N/A
- ERO N/A
- EPS Growth
- GERN N/A
- ERO N/A
- EPS
- GERN N/A
- ERO 0.17
- Revenue
- GERN $29,480,000.00
- ERO $464,134,000.00
- Revenue This Year
- GERN $31,918.56
- ERO $14.91
- Revenue Next Year
- GERN $289.41
- ERO $75.75
- P/E Ratio
- GERN N/A
- ERO $77.69
- Revenue Growth
- GERN 9199.68
- ERO 8.51
- 52 Week Low
- GERN $1.64
- ERO $12.70
- 52 Week High
- GERN $5.34
- ERO $24.34
- Technical
- Relative Strength Index (RSI)
- GERN 31.98
- ERO 40.85
- Support Level
- GERN $2.49
- ERO $12.70
- Resistance Level
- GERN $2.84
- ERO $14.67
- Average True Range (ATR)
- GERN 0.15
- ERO 0.67
- MACD
- GERN -0.01
- ERO -0.01
- Stochastic Oscillator
- GERN 13.33
- ERO 5.08
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.